ESPE Yearbook of Paediatric Endocrinology

To read the full abstract: J Endocrinol Invest. 2020 Feb;43(2):209–217. giulia.rodari@unimi.itGrowth hormone deficiency (GHD) is the most common endocrine late effect in children with tumours involving the hypothalamus-pituitary (HP) area or exposed to cranial, craniospinal or total body radiotherapy (RT). The location of brain tumours in continuity with the sellar/suprasellar area and HP radiatio...

To read the full abstract: Horm Res Paediatr. 2018; 90(5): 314This single-centre, retrospective study analyzes the screening role of low IGF-1 levels in the diagnosis of growth hormone deficiency (GHD) in a cohort of 158 childhood cancer survivors (CCS) and in a selected sub-cohort of 117 CCS who received radiation for tumours not directly involving the hypothalamic-pituitary (HP) area (...

J Clin Endocrinol Metab. 2020; 105: e3730–41. https://pubmed.ncbi.nlm.nih.gov/32706856/This retrospective analysis of the Pfizer International Growth Database (KIGS) included 1149 cancer survivors with growth hormone deficiency (GHD) who had received growth hormone therapy (GHT) for at least 5 years. Patients with craniopharyngioma had the best 5-year growth response ...

Brief Summary: This is the first International Consensus Guidance on the monitoring of children, adolescents and adults with early-stage (pre-symptomatic) Type 1 Diabetes (T1D), defined as those individuals positive for islet autoantibodies and with either normoglycemia or dysglycemia.With the progressive increase in screening programs for T1D around the world, there is a growing number of individuals identified with early-stages pre-symptomatic T1D (1)....